Onconova Therapeutics- Warrants (01/08/2021) PEG Ratio

Onconova Therapeutics- Warrants (01/08/2021) (ONTXW) currently reports a PEG ratio of -0.18. That is below the Healthcare sector average of 27.75. Use the charts on this page to explore Onconova Therapeutics- Warrants (01/08/2021)'s PEG ratio history and peer comparisons.

Onconova Therapeutics- Warrants (01/08/2021)'s PEG ratio of -0.18 is lower than the Healthcare sector average of 27.75. That is roughly 100.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Onconova Therapeutics- Warrants (01/08/2021)'s market price to a fundamental measure such as earnings, sales, or book value. At -0.18, ONTXW can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -0.18, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for Onconova Therapeutics- Warrants (01/08/2021), and consider following ONTXW for alerts when major investors trade the stock.

Onconova Therapeutics- Warrants (01/08/2021) is classified in the Healthcare sector. On PEG ratio, it currently shows -0.18 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONTXW with unrelated industries.